GLP-1 & Metabolic

Cagrilintide

SKU NA-012CAS 1415456-99-7MW 3731.9
98.9% HPLCThird-party testedRUO · Research use only
RUOThis product is sold for laboratory research use only. It is not a drug or supplement and is not for human or veterinary consumption, diagnostic or therapeutic use.

Price range: $38.00 through $57.99

HPLC verifiedPurity confirmed per lot
COA includedLot-specific certificate
Cold-chainShipped 2-8°C with packs
Lot traceableDocumented to dispatch
Description

Cagrilintide is a long-acting amylin analog research peptide supplied lyophilized. Each lot is verified by RP-HPLC and ships with a Certificate of Analysis.

Specifications
CompoundCagrilintide
ClassificationLong-acting amylin analog
CAS number1415456-99-7
Molecular formulaC172H272N50O55
Molecular weight3731.9 g/mol
Purity98.9% by RP-HPLC (area %)
Physical formLyophilized powder
AppearanceWhite to off-white solid
ReconstitutionBacteriostatic water
Lab documentation

Each production lot is released against an analytical specification and ships with the corresponding Certificate of Analysis.

Certificate of AnalysisLot CAG-2406-A
MethodRP-HPLC / UV 214 nm
Purity (area %)98.9%
IdentityESI-MS confirmed
AppearanceWhite to off-white solid
Storage & handling

Storage. Store lyophilized material at -20°C protected from light and moisture for long-term stability. After reconstitution, keep at 2-8°C and use within the documented in-use window.

Handling. Allow sealed vials to equilibrate to room temperature before opening to limit condensation. Reconstitute with the listed diluent using standard aseptic laboratory technique. Avoid repeated freeze-thaw cycles.

Safety. Handle as a laboratory research chemical. Wear appropriate PPE and follow your institution's chemical-handling and waste-disposal procedures.

Shipping

Dispatch. In-stock orders are processed on business days and shipped with temperature-controlled packaging and gel packs to preserve material integrity in transit.

Tracking. A tracking reference is issued at dispatch. Lab accounts can consolidate shipments and arrange standing orders.

Eligibility. Orders are accepted from researchers, resellers and institutions for laboratory research use only.

Selected research

Literature referencing this compound.

Publications relevant to this molecule, provided for research reference. Inclusion does not imply an approved use or any claim about the products sold here.

Phase 2 RCT
Lancet. 2021;398(10317):2160–2172
Once-weekly cagrilintide for weight management in people with overweight and obesity: a phase 2 trial
Lau DCW, Erichsen L, Francisco AM, et al.
Phase 1b RCT
Lancet. 2021;397(10286):1736–1748
Concomitant cagrilintide with semaglutide 2·4 mg for weight management: a phase 1b trial
Enebo LB, Berthelsen KK, Kankam M, et al.